- Home
- TOST vs ZBH Comparison
TOST vs ZBH Comparison
Compare TOST & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOST
- ZBH
- Stock Information
- Founded
- TOST 2012
- ZBH 1927
- Country
- TOST United States
- ZBH United States
- Employees
- TOST N/A
- ZBH N/A
- Industry
- TOST EDP Services
- ZBH Industrial Specialties
- Sector
- TOST Technology
- ZBH Health Care
- Exchange
- TOST Nasdaq
- ZBH Nasdaq
- Market Cap
- TOST 21.1B
- ZBH 19.9B
- IPO Year
- TOST 2021
- ZBH N/A
- Fundamental
- Price
- TOST $34.28
- ZBH $89.08
- Analyst Decision
- TOST Buy
- ZBH Buy
- Analyst Count
- TOST 23
- ZBH 19
- Target Price
- TOST $45.26
- ZBH $108.56
- AVG Volume (30 Days)
- TOST 8.5M
- ZBH 2.3M
- Earning Date
- TOST 11-04-2025
- ZBH 11-05-2025
- Dividend Yield
- TOST N/A
- ZBH 1.08%
- EPS Growth
- TOST N/A
- ZBH N/A
- EPS
- TOST 0.43
- ZBH 4.03
- Revenue
- TOST $5,858,000,000.00
- ZBH $8,010,900,000.00
- Revenue This Year
- TOST $24.86
- ZBH $8.20
- Revenue Next Year
- TOST $20.33
- ZBH $5.92
- P/E Ratio
- TOST $81.45
- ZBH $21.98
- Revenue Growth
- TOST 25.76
- ZBH 5.47
- 52 Week Low
- TOST $28.12
- ZBH $85.33
- 52 Week High
- TOST $49.66
- ZBH $114.72
- Technical
- Relative Strength Index (RSI)
- TOST 39.27
- ZBH 34.94
- Support Level
- TOST $35.52
- ZBH $86.51
- Resistance Level
- TOST $38.64
- ZBH $91.28
- Average True Range (ATR)
- TOST 1.79
- ZBH 2.89
- MACD
- TOST -0.10
- ZBH -0.69
- Stochastic Oscillator
- TOST 5.38
- ZBH 21.24
About TOST Toast Inc.
Toast is an end-to-end technology platform designed to address the complex needs of the restaurant industry. The company generates point-in-time revenue through sales of its restaurant-grade hardware and recurring revenue in the form of take rates on restaurant transaction volume as well as subscriptions to its software solutions. As of fiscal 2024, the company provided services to 134,000 restaurant locations primarily in the US. Toast's typical customer is a mid-market restaurant generating slightly more than $1 million in revenue annually.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.